Jevtana (cabazitaxel)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Jevtana (cabazitaxel), covering 2017-06-02 to 2018-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma [Phase 2]